In response to the company announcing the FDA approval of a few new instruments, shares of TransEnterix (NYSEMKT:TRXC), a medical device company focused on robotic surgery, jumped 10% as of 2:45 p.m. EDT on Thursday.
So whatTransEnterix stated that it has won FDA approval for its 3-millimeter instrument set as well as some additional 5-millimeter instruments. These new products will be used in conjunction with the company's Senhance system in digital laparoscopy procedures.
Image source: Getty Images.
The company believes that these tiny products will enable surgeons to operate through incisions that are so small that they will be considered "virtually scarless" for patients.
TransEnterix's CEO Todd Pope was thrilled with the news:
Best Medical Stocks To Own For 2019: Manitex International Inc.(MNTX)
Advisors' Opinion:- [By Ethan Ryder]
Manitex International Inc (NASDAQ:MNTX) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $12.95 and last traded at $12.61, with a volume of 655 shares changing hands. The stock had previously closed at $12.94.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Manitex International (MNTX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Manitex International (MNTX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Get a free copy of the Zacks research report on Manitex International (MNTX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Best Medical Stocks To Own For 2019: Contango Oil & Gas Company(MCF)
Advisors' Opinion:- [By Stephan Byrd]
COPYRIGHT VIOLATION NOTICE: “Contango Oil & Gas (MCF) Short Interest Update” was originally published by Ticker Report and is owned by of Ticker Report. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.tickerreport.com/banking-finance/3346537/contango-oil-gas-mcf-short-interest-update.html.
- [By Joseph Griffin]
Fondren Management LP purchased a new position in shares of Contango Oil & Gas (NYSEAMERICAN:MCF) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 60,000 shares of the oil and natural gas company’s stock, valued at approximately $341,000. Fondren Management LP owned 0.23% of Contango Oil & Gas as of its most recent filing with the SEC.
- [By Joseph Griffin]
Contango Oil & Gas (NASDAQ:MCF) was downgraded by equities researchers at Seaport Global Securities from a “buy” rating to a “neutral” rating in a research report issued on Friday.
- [By Ethan Ryder]
Fmr LLC increased its position in shares of Contango Oil & Gas (NYSEAMERICAN:MCF) by 33.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,583,039 shares of the oil and natural gas company’s stock after buying an additional 899,900 shares during the quarter. Fmr LLC owned 13.93% of Contango Oil & Gas worth $20,352,000 at the end of the most recent quarter.
Best Medical Stocks To Own For 2019: CBL & Associates Properties, Inc.(CBL)
Advisors' Opinion:- [By Joseph Griffin]
Get a free copy of the Zacks research report on CBL & Associates Properties (CBL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Get a free copy of the Zacks research report on CBL & Associates Properties (CBL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Matthew Frankel]
Mall REIT CBL & Associates (NYSE:CBL) reported its second-quarter earnings on Wednesday evening, and the results weren't pretty. As of 3 p.m. EDT on Thursday, the stock has fallen by more than 11%.
- [By Max Byerly]
Schwab Charles Investment Management Inc. lifted its holdings in shares of CBL & Associates Properties, Inc. (NYSE:CBL) by 19.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,853,945 shares of the real estate investment trust’s stock after buying an additional 638,513 shares during the quarter. Schwab Charles Investment Management Inc. owned about 2.23% of CBL & Associates Properties worth $21,467,000 at the end of the most recent quarter.
- [By Shane Hupp]
Shares of CBL & Associates Properties, Inc. (NYSE:CBL) have received a consensus rating of “Sell” from the seventeen research firms that are presently covering the stock, MarketBeat reports. Ten research analysts have rated the stock with a sell rating and six have given a hold rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $4.44.
- [By Demitrios Kalogeropoulos]
CBL & Associates Properties (NYSE:CBL) stock trailed the market by shedding 18% last month compared to a 3% increase in the S&P 500, according to data provided by S&P Global Market Intelligence.
Best Medical Stocks To Own For 2019: Just Hold Your Nose and Dive Into Under Armour Inc (UAA)
Advisors' Opinion:- [By Jeremy Bowman]
Over the past five years, Nike has been the clear winner as Disney has struggled with the transition to streaming. Nike separated itself from Disney recently when it returned to steady growth in key markets and rival Under Armour (NYSE:UA) (NYSE:UAA) began falling apart.
- [By ]
1. Under Armour (NYSE: UAA)
This nearly $9 billion market cap athletic performance apparel, footwear, and accessories company has roared higher during the first half of January 2019. Rocketing over 11% in several weeks, Under Armour boasts both the fundamentals and technicals to continue higher into 2019. - [By Jeremy Bowman]
Nike's recent move draws a sharp contrast with statements by Under Armour (NYSE:UA) (NYSE:UAA) CEO Kevin Plank last year, when he aligned himself with President Trump shortly after the inauguration. At a time when Trump was immersed in controversy following the chaotic implementation of the administration's travel ban, Plank called Trump a "real asset for the country," citing his business experience and business-friendly policies. Plank was immediately confronted with a backlash of his own making as fans threatened to boycott the brand. NBA star point guard Stephen Curry of the Golden State Warriors and Under Armour's marquee star, pushed back against Plank, saying that Trump was an asset if you take off the last two letters from the word. Actor and retired professional wrestler Dwayne "The Rock" Johnson expressed a similar sentiment.
- [By Jon C. Ogg]
Under Armour Inc. (NYSE: UAA) was maintained as Neutral with a $20 price target (versus a $22.21 close, after a 6.9% post-earnings gain) at Wedbush, with the firm noting that there is no need to rush into the shares at the current level after earnings. Credit Suisse also stuck with a Neutral rating.
- [By Ethan Ryder]
Teacher Retirement System of Texas cut its holdings in shares of Under Armour Inc Class A (NYSE:UAA) by 20.4% in the first quarter, Holdings Channel reports. The institutional investor owned 40,961 shares of the company’s stock after selling 10,467 shares during the quarter. Teacher Retirement System of Texas’ holdings in Under Armour Inc Class A were worth $670,000 as of its most recent filing with the Securities & Exchange Commission.
Best Medical Stocks To Own For 2019: SandRidge Permian Trust(PER)
Advisors' Opinion:- [By Max Byerly]
Media coverage about SandRidge Permian Trust (NYSE:PER) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. SandRidge Permian Trust earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave news headlines about the oil and gas producer an impact score of 46.3601951962152 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
No comments:
Post a Comment